Piramal Pharma Rights Issue Details 2023

Piramal Pharma Company was incorporated in Mumbai, Maharashtra on March 4, 2020. They are a pharmaceutical company with global operations, providing end-to-end pharma services to customers and a portfolio of differentiated pharma products across a domestic and global distribution network. They operate under three business verticals (i) Piramal Pharma Solutions (PPS), an integrated contract development and manufacturing organization (DMO); (ii) Piramal Critical Care (PCC), a complex hospital generics (CHG) business; and (iii) India consumer healthcare (CH) business, selling over-the-counter (OTC) products.

Its integrated network of facilities for CDMO operations is located across India, the UK and North America. They have obtained and maintained requisite approvals from various global regulatory agencies. they have development and manufacturing capabilities in areas such as high-potency APIs, antibody-drug conjugates (ADC), peptides, sterile injectables and hormonal products.

Its CDMO provides integrated drug discovery, development, and manufacturing services for both drug substances i.e. active pharmaceutical ingredients (APIs) and drug products i.e. formulations across the lifecycle of a molecule from discovery and clinical development to commercial launch. It has a diverse customer base of over 500 customers comprising bal innovator pharma companies, emerging biopharma companies and generic pharma companies.